King, Gentry http://orcid.org/0000-0002-7525-8802
Javle, Milind
Article History
Accepted: 24 May 2021
First Online: 16 July 2021
Declarations
:
: Gentry King declares that he has no conflict of interest. Milind Javle has received research funding from QED Therapeutics, Taiho Pharmceutical Group, Basilea Pharmaceutical AG, EMD Serono, Meclun, AstraZeneca, and Merck; and has received compensation for service as a consultant from QED Therapeutics, Taiho, EMD Serono, AstraZeneca, and Merck.